TABLE 3.
CL at 30% BL |
CL at 50% BL |
|||
---|---|---|---|---|
2–8 Group1 | 4–8 Group | 2–8 Group | 4–8 Group | |
N | 8 | 8 | 7 | 8 |
Body length (mm) | 88.5 ± 7.6 | 87.8 ± 5.4 | 89.4 ± 13.9 | 88.8 ± 8.1 |
Di | 9.6 ± 4.92 | 7.6 ± 4.1 | 7.1 ± 3.4 | 5.5 ± 4.6 |
M cells (M1–M3) | 2.4 ± 1.4 | 3.9 ± 1.4 | 3.3 ± 1.4 | 3.4 ± 1.4 |
MRN | 25.6 ± 4.2 | 28.8 ± 8.5 | 30.9 ± 4.8 | 34.3 ± 8.3 |
I cells (I1–I4) | 2.9 ± 0.8 | 4.3 ± 2.0 | 2.7 ± 1.1 | 4.4 ± 2.2 |
aARRN | 38.4 ± 8.1 | 34.5 ± 5.2 | 31.9 ± 4.7 | 30.0 ± 8.5 |
IARRN | 50.3 ± 13.9 | 48.9 ± 6.6 | 43.3 ± 6.1 | 39.5 ± 13.9 |
mARRN | 23.0 ± 8.0 | 21.8 ± 2.1 | 20.0 ± 5.7 | 25.0 ± 5.2 |
B cells (B1–B5) | 4.3 ± 1.3 | 4.0 ± 1.7 | 2.3 ± 1.0 | 4.9 ± 2.3 |
Mau and AM cells | 1.9 ± 1.0 | 1.6 ± 0.5 | 1.1 ± 0.7 | 1.9 ± 0.8 |
aMRRN | 32.3 ± 6.3 | 27.1 ± 6.3 | 31.3 ± 7.0 | 27.9 ± 7.1 |
pMRRN | 53.6 ± 11.4 | 47.3 ± 7.9 | 44.1 ± 10.5 | 52.4 ± 7.1 |
PRRN | 293.6 ± 64.4 | 244.1 ± 31.3 | 249.4 ± 43.9 | 237.1 ± 48.7 |
ALV | 11.4 ± 4.3 | 12.3 ± 5.9 | 11.7 ± 2.4 | 11.9 ± 4.4 |
DLV | 12.8 ± 8.9 | 9.4 ± 5.7 | 7.1 ± 3.7 | 11.3 ± 4.4 |
PLV | 73.5 ± 34.4 | 58.0 ± 10.6 | 57.7 ± 31.8 | 65.6 ± 24.0 |
PON | 1.8 ± 2.0 | 1.8 ± 2.4 | 0.4 ± 1.1 | 1.6 ± 1.5 |
Animal groups (“D-R” groups; see explanation in Materials and Methods, Table 2, and Fig. 1B, C).
Mean ± SD for numbers of labeled descending brain neurons on both sides of the brain (these values were not significantly different from controls at 8-week recovery times; see middle column in Table 1; one-way ANOVA).